If you sold your biotech stock based on the Fed chair’s assessment of the market in July, you’d be sorry now. At a recent International Monetary Fund event in Washington, D.C., Federal Reserve Chair Janet Yellen opined about the “potential dangers” posed by “quite high” stock market valuations. This was not her first market prognostication.